ARCHIVED: Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer according to study
A multi-center study led by researchers at?Âé¶¹Ó³» MD Anderson Cancer Center?revealed that a liquid biopsy test called Guardant360?, is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced?non-small cell lung cancer (NSCLC), has a faster turn-around time, and has the potential to support identification of more patients who can be treated with targeted therapy...
ARCHIVED: Nearly $20 million awarded by CPRIT to MD Anderson
Âé¶¹Ó³» MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas...
ARCHIVED: Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism
Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing...
ARCHIVED: Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
Researchers at Âé¶¹Ó³» MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumor regression in mouse models of small cell lung cancer (SCLC), suggesting a promising new approach for treating patients with this aggressive cancer.
The preclinical research, published today in Cancer Discovery...
ARCHIVED: Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy...
ARCHIVED: New therapeutic target found for aggressive pediatric cancers with few treatment options
Researchers at Âé¶¹Ó³» MD Anderson Cancer Center have discovered that malignant rhabdoid tumors (MRT), a rare pediatric cancer...
ARCHIVED: MD Anderson supports World Cancer Day call for action to end cancer
As an institution devoted to eliminating cancer for patients in Texas, the nation and around the world, Âé¶¹Ó³» MD Anderson...